PRE PRENETICS GLOBAL LIMITED

Prenetics CEO Danny Yeung Publishes "The Dual-Engine Revolution" Manifesto: A Blueprint for the Future of Health + Wealth

Prenetics CEO Danny Yeung Publishes "The Dual-Engine Revolution" Manifesto: A Blueprint for the Future of Health + Wealth

Comprehensive Document Reveals Strategic Vision Behind Company's Unprecedented Growth and Bitcoin Treasury Strategy

IM8, the Fastest-Growing Supplement Brand in Industry History, Reaching Reaches $100M ARR in 11 Months Since Launch

IM Projects $180-$200 Million in FY 2026 Revenue

CHARLOTTE, N.C., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE (“Prenetics” or the “Company”), a leading health sciences company, today announced the publication of a comprehensive manifesto authored by CEO and Co-Founder Danny Yeung, titled "The Dual-Engine Revolution: A Manifesto for Building the Future of Health + Wealth." The document provides unprecedented transparency into the Founder led Company's strategic thinking, revealing the entrepreneurial journey and pattern recognition that led to Prenetics' groundbreaking approach of combining explosive healthcare growth with sophisticated Bitcoin treasury management.

The manifesto is available in multiple formats to suit different audiences and preferences, including a comprehensive 32-page version, an executive summary, a video presentation, and an audio narration. It outlines how integrating healthcare growth with Bitcoin treasury management can create meaningful, long-term value:

Healthcare Engine (IM8): The brand achieved $100 million in annual recurring revenue within 11 months of launch: the fastest growth in supplement industry history. Co-founded with David Beckham and backed by World #1 tennis champion Aryna Sabalenka, IM8 is projecting $180 to $200 million in revenue for 2026.

Bitcoin Treasury Engine: As of today, the Company holds 277 BTC and is consistently adding to its position through a disciplined daily accumulation strategy of 1 BTC, Prenetics is building what Yeung calls a "fortress of value" that provides financial resilience and appreciation potential independent of traditional financial systems.

The Synergy: IM8's explosive growth generates substantial cash flows that enable sophisticated Bitcoin treasury management, while the Bitcoin treasury provides financial appreciation that can accelerate healthcare expansion—creating a virtuous cycle that single-engine companies cannot match.

Access to the manifesto in all formats at:

For comprehensive financial information and investor materials, please visit: 

For real-time access to the Company’s Bitcoin holdings, please visit 

Investor Relations Contact:

 

 

Angela Cheung

Investor Relations / Corporate Finance 

 

About Prenetics

Prenetics (NASDAQ: PRE) is a leading health sciences company redefining the future of health and longevity through IM8 — its flagship consumer brand co-founded with David Beckham and championed by World No. 1 and four-time Grand Slam winner Aryna Sabalenka — now the fastest-growing supplement brand globally, reaching $100 million in annual recurring revenue within just 11 months of launch — the fastest growth ever recorded in the global history of the supplements industry, even outpacing today’s leading AI startups.

As the first consumer health company to establish a Bitcoin Treasury, Prenetics continues to pioneer at the intersection of health innovation and digital assets — purchasing 1 Bitcoin per day, now totaling 277 BTC as of October 29, 2025.

Forward-Looking Statements

This press release contains forward-looking statements. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates,” and similar statements. Prenetics may also make written or oral forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission, in its annual report to shareholders, in press releases and other written materials, and in oral statements made by its officers, directors, or employees to third parties. Statements that are not historical facts, including statements about Prenetics’ beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: the Company’s ability to meet all of the terms and conditions of the offering and complete the offering, the Company’s ability to execute its new Bitcoin treasury strategy; the volatility of Bitcoin; the Company’s ability to manage its growth and expansion; the company’s ability to compete in the highly competitive consumer health market; and other risks and uncertainties. Further information regarding these and other risks is included in Prenetics’ filings with the U.S. Securities and Exchange Commission. All information provided in this press release is as of the date of this press release, and Prenetics does not undertake any obligation to update any forward-looking statement, except as required under applicable law.



EN
29/10/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on PRENETICS GLOBAL LIMITED

 PRESS RELEASE

Prenetics Bolsters Bitcoin Treasury with Strategic Acquisition of 100 ...

Prenetics Bolsters Bitcoin Treasury with Strategic Acquisition of 100 Bitcoin, IM8 Reaches $100M ARR Additional Bitcoin Acquisition Follows Immediately on $44 Million Equity Offering Company now holds a total of 378 BTC (valued at ~$46 Million) CHARLOTTE, N.C., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading health sciences company, today announces the acquisition of 100 Bitcoin, at an average price of $109,594 per Bitcoin. This acquisition demonstrates the Company's dedication and continued discipline to building its Bi...

 PRESS RELEASE

Prenetics CEO Danny Yeung Publishes "The Dual-Engine Revolution" Manif...

Prenetics CEO Danny Yeung Publishes "The Dual-Engine Revolution" Manifesto: A Blueprint for the Future of Health + Wealth Comprehensive Document Reveals Strategic Vision Behind Company's Unprecedented Growth and Bitcoin Treasury Strategy IM8, the Fastest-Growing Supplement Brand in Industry History, Reaching Reaches $100M ARR in 11 Months Since Launch IM Projects $180-$200 Million in FY 2026 Revenue CHARLOTTE, N.C., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE (“Prenetics” or the “Company”), a leading health sciences company, today announced the publication o...

 PRESS RELEASE

Prenetics Announces Closing of Approx. $44.0 Million Equity Offering t...

Prenetics Announces Closing of Approx. $44.0 Million Equity Offering to Fuel IM8’s Global Expansion and Bitcoin Treasury Strategy CHARLOTTE, N.C., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading health sciences company, today announced the closing of its previously announced best efforts public offering (the “Offering”) of (i) 2,722,642 Class A ordinary shares, par value $0.0015 per share, of the Company (the “Ordinary Shares,” the Ordinary Shares being sold in the Offering, the “Shares”), (ii) warrants of the Company to p...

 PRESS RELEASE

Prenetics Announces Oversubscribed Approximately $48 Million Equity Of...

Prenetics Announces Oversubscribed Approximately $48 Million Equity Offering with Potential for $216 Million in Total Proceeds to Fuel IM8’s Global Expansion and Bitcoin Treasury Strategy Distinguished Investor Group Includes Kraken, American Ventures, Exodus (NYSE: EXOD), XtalPi (2228.hk), DL Holdings (1709.hk) GPTX by Jihan Wu and Leading Institutions World No. 1 and 4-time Grand Slam champion Aryna Sabalenka expands her stake in Prenetics Adrian Cheng, one of Asia’s most influential visionaries and an original cornerstone investor in Prenetics’ IPO increases his stake, reflecting endur...

 PRESS RELEASE

Prenetics Announces $48.0 Million Equity Offering to Fuel IM8’s Global...

Prenetics Announces $48.0 Million Equity Offering to Fuel IM8’s Global Expansion and Bitcoin Treasury Strategy CHARLOTTE, N.C., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading health sciences company, today announced the successful pricing of a best efforts public offering (the “Offering”) of (i) 2,992,596 Class A ordinary shares, par value $0.0015 per share, of the Company (the “Ordinary Shares,” the Ordinary Shares being sold in the Offering, the “Shares”) (or pre-funded warrants of the Company to purchase Ordinary Share...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch